Siegel, R., Miller, K., Fuchs, H. & & Jemal, A. (2021). Cancer statistics. CA: A Cancer Journal for Clinicians, 71(1), 7–33. https://doi.org/10.3322/caac.21654.
Burmeister, C., Khan, S., Schäfer, G., Mbatani, N., Adams, T., Moodley, J., & Prince, S. (2022). Cervical cancer therapies: current challenges and future perspectives. Tumour Virus Research, 13, 200238. https://doi.org/10.1016/j.tvr.2022.200238.
Article CAS PubMed PubMed Central Google Scholar
Cohen, P., Jhingran, A., Oaknin, A., & Denny, L. (2019). Cervical cancer. Lancet, 393(10167), 169–182.
FIGO (International Federation of Gynecology and Obstetrics) 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 2006, S1–257. https://doi.org/10.1016/s0020-7292(06)60025-8.
Tsuda, N., Watari, H., & Ushijima, K. (2016). Chemotherapy and molecular targeting therapy for recurrent cervical cancer. Chinese Journal of Cancer Research, 28(2), 241–253. https://doi.org/10.21147/j.issn.1000-9604.2016.02.14.
Article CAS PubMed PubMed Central Google Scholar
Yu, B., Chen, L., Zhang, W., Li, Y., Zhang, Y., Gao, Y., Teng, X., Zou, L., Wang, Q., & Jia, H., et al. (2020). TOP2A and CENPF are synergistic master regulators activated in cervical cancer. BMC Medical Genomics, 13(1), 145. https://doi.org/10.1186/s12920-020-00800-2.
Article CAS PubMed PubMed Central Google Scholar
Rattner, J., Rao, A., Fritzler, M., Valencia, D. & & Yen, T. (1993). CENP-F is a .ca 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization. Cell Motility and The Cytoskeleton, 26(3), 214–226. https://doi.org/10.1002/cm.970260305.
Article CAS PubMed Google Scholar
Ma, L., Zhao, X., & Zhu, X. (2006). Mitosin/CENP-F in mitosis, transcriptional control, and differentiation. Journal of Biomedical Science, 13(2), 205–213. https://doi.org/10.1007/s11373-005-9057-3.
Article CAS PubMed Google Scholar
Varis, A., Salmela, A., & Kallio, M. (2006). Cenp-F (mitosin) is more than a mitotic marker. Chromosoma, 115(4), 288–295. https://doi.org/10.1007/s00412-005-0046-0.
Article CAS PubMed Google Scholar
Yang, X., Miao, B., Wei, C., Dong, R., Gao, P., Zhang, X., Lu, J., Gao, C., Wang, X., & Sun, H., et al. (2019). Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression. Cancer Science, 110(7), 2133–2144. https://doi.org/10.1111/cas.14037.
Article CAS PubMed PubMed Central Google Scholar
Chen, E., Qin, X., Peng, K., Li, Q., Tang, C., Wei, Y., Yu, S., Gan, L., & Liu, T. (2019). HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis. Aging, 11(18), 7473–7491. https://doi.org/10.18632/aging.102254.
Article CAS PubMed PubMed Central Google Scholar
Chen, Q., Xu, H., Zhu, J., Feng, K., & Hu, C. (2020). LncRNA MCM3AP-AS1 promotes breast cancer progression via modulating miR-28-5p/CENPF axis. Biomedicine & Pharmacotherapy, 128, 110289. https://doi.org/10.1016/j.biopha.2020.110289.
Li, M., Zhang, M., Dong, H., Li, A., Teng, H., Liu, A., Xu, N., & Qu, Y. (2021). Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. International Journal of Medical Sciences, 18(2), 494–504. https://doi.org/10.7150/ijms.49041.
Article CAS PubMed PubMed Central Google Scholar
Dai, Y., Liu, L., Zeng, T., Zhu, Y., Li, J., Chen, L., Li, Y., Yuan, Y., Ma, S., & Guan, X. (2013). Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma. Biochemical and Biophysical Research Communications, 436(4), 711–718. https://doi.org/10.1016/j.bbrc.2013.06.021.
Article CAS PubMed Google Scholar
Shin, D., Kim, E., Lee, J., & Roh, J. (2018). Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Free Radical Biology & Medicine, 129, 454–462. https://doi.org/10.1016/j.freeradbiomed.2018.10.426.
Chen, P., Wu, J., Ding, C., Lin, C., Pan, S., Bossa, N., Xu, Y., Yang, W., Mathey-Prevot, B., & Chi, J. (2020). Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism. Cell Death and Differentiation, 27(3), 1008–1022. https://doi.org/10.1038/s41418-019-0393-7.
Article CAS PubMed Google Scholar
Liang, Y., Wang, Y., Zhang, Y., Ye, F., Luo, D., Li, Y., Jin, Y., Han, D., Wang, Z., & Chen, B., et al. (2023). HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer. Cell Death & Disease, 14(7), 434 https://doi.org/10.1038/s41419-023-05972-0.
Sun, J., Huang, J., Lan, J., Zhou, K., Gao, Y., Song, Z., Deng, Y., Liu, L., Dong, Y., & Liu, X. (2019). Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer. Cancer Cell International, 19, 264. https://doi.org/10.1186/s12935-019-0986-8.
Article CAS PubMed PubMed Central Google Scholar
Chen, H., Wang, X., Wu, F., Mo, X., Hu, C., Wang, M., Xu, H., Yao, C., Xia, H., Lan, L. Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer. Genomics 2021, (1 Pt.2), 113. https://doi.org/10.1016/j.ygeno.2020.10.039.
Xiaofei, J., Mingqing, S., Miao, S., Yizhen, Y., Shuang, Z., Qinhua, X., & Kai, Z. (2021). Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway. Biochemical and Biophysical Research Communications, 545, 81–88. https://doi.org/10.1016/j.bbrc.2021.01.028.
Article CAS PubMed Google Scholar
Xiong, J., Nie, M., Fu, C., Chai, X., Zhang, Y., He, L., Sun, S. Hypoxia enhances HIF1α transcription activity by upregulating KDM4A and mediating H3K9me3, thus inducing ferroptosis resistance in cervical cancer cells. Stem Cells International 2022. https://doi.org/10.1155/2022/1608806.
Zhao, M., Liu, P., Sun, C., Pei, L., & Huang, Y. (2022). In VitroPropofol augments paclitaxel-induced cervical cancer cell ferroptosis. Frontiers in Pharmacology, 13, 816432. https://doi.org/10.3389/fphar.2022.816432.
Article CAS PubMed PubMed Central Google Scholar
Ren, Z., Hu, M., Wang, Z., Zheng, H. Ferroptosis-related genes in lung adenocarcinoma: prognostic signature and immune, drug resistance, mutation analysis. Frontiers in Genetics 2021. https://doi.org/10.3389/fgene.2021.672904.
Liu, J., Wang, Y., Meng, H., Yin, Y., Zhu, H., & Ni, T. (2021). Identification of the prognostic signature associated with tumor immune microenvironment of uterine corpus endometrial carcinoma based on ferroptosis-related genes. Frontiers in Cell and Developmental Biology, 9, 735013. https://doi.org/10.3389/fcell.2021.735013.
Article PubMed PubMed Central Google Scholar
Xu, T., Ding, W., Ji, X., Ao, X., Liu, Y., Yu, W., Wang, J. Molecular mechanisms of ferroptosis and its role in cancer therapy. Journal of Cellular and Molecular Medicine 2019, 23 (8). https://doi.org/10.1111/jcmm.14511.
Garrick, M. D., Singleton, S. T., Vargas, F., Kuo, H. C., Zhao, L., KNÖPFEL, M., Davidson, T., Costa, M., Paradkar, P., Roth, J. A. DMT1: Which metals does it transport? Biological Research 2006, 39 (1). https://doi.org/10.4067/S0716-97602006000100009.
Hirschhorn, T., & Stockwell, B. (2019). The development of the concept of ferroptosis. Free Radical Biology & Medicine, 133, 130–143. https://doi.org/10.1016/j.freeradbiomed.2018.09.043.
Gamage, S. M. K., Lee, K. T. W., Dissabandara, D. L. O., Lam, K. Y., & Gopalan, V. (2021). Dual role of heme iron in cancer; promotor of carcinogenesis and an inducer of tumour suppression. Experimental and Molecular Pathology, 120(6), 104642. https://doi.org/10.1016/j.yexmp.2021.104642.
Article CAS PubMed Google Scholar
Fustinoni-Reis, A., Arruda, S., Dourado, L., da Cunha, M., & Siqueira, E. (2016). Tucum-Do-Cerrado (Bactris setosa Mart.) consumption modulates iron homeostasis and prevents iron-induced oxidative stress in the rat liver. Nutrients, 8(2), 38 https://doi.org/10.3390/nu8020038.
Article CAS PubMed PubMed Central Google Scholar
Deng, S., Wu, D., Li, L., Li, J., & Xu, Y. (2021). TBHQ attenuates ferroptosis against 5-fluorouracil-induced intestinal epithelial cell injury and intestinal mucositis via activation of Nrf2. Cellular & Molecular Biology Letters, 26(1), 48 https://doi.org/10.1186/s11658-021-00294-5.
Boss, A., Freeborn, R., Duriancik, D., Kennedy, R., Gardner, E., & Rockwell, C. (2018). The Nrf2 activator tBHQ inhibits the activation of primary murine natural killer cells. Food and Chemical Toxicology, 121, 231–236. https://doi.org/10.1016/j.fct.2018.08.067.
Article CAS PubMed PubMed Central Google Scholar
Meng, X., Zhang, C., Guo, Y., Han, Y., Wang, C., Chu, H., Kong, L., & Ma, H. (2020). TBHQ attenuates neurotoxicity induced by methamphetamine in the VTA through the Nrf2/HO-1 and PI3K/AKT signaling pathways. Oxidative Medicine and Cellular Longevity, 2020, 8787156. https://doi.org/10.1155/2020/8787156.
留言 (0)